Evaluation of Protective Effect of Methyl Sulfonyl Methane on Colon Ulcer Induced by Alendronate


Colon ulcer
Methyl sulfonyl methane

How to Cite

Safaa William Mdawar, Shaza Anwar Al Laham, & Ahmad Izzat Al-Manadili. (2017). Evaluation of Protective Effect of Methyl Sulfonyl Methane on Colon Ulcer Induced by Alendronate. Journal of Pharmacy and Nutrition Sciences, 7(3), 130–135. https://doi.org/10.6000/1927-5951.2017.07.03.9


Background: Bisphosphonates represent a new class of drugs that have shown very promising therapeutic efficacy in the treatment of a number of diseases associated with abnormally accelerated bone resorption including osteoporosis, Paget’s disease, and hypercalcemia of malignancy. As an increasing number of these drugs become available for clinical use in the treatment of the millions of individuals with these skeletal diseases, evidence is becoming available that their chronic usage may be associated with a number of gastrointestinal side effects, such as diarrhea, abdominal pain and inflammation, and erosions and ulceration of the upper gastrointestinal tract. Methyl sulfonyl methane (MSM) which is used for osteoarthritis was used to prevent bisphosphonates ulceration. Our objective was to study the preventive effect of MSM against colon ulcer induced by Alendronate (ALN) in rats. The experiments had been done on 8 white wistar rats for each group. The gastric ulcer has been induced by administration of Alendronate (20mg/kg/day) by gavage for 4 days. MSM (400mg/kg/day) has been given for the protective group for 4 days before administration of Alendronate. The ulcers in rats' colon were examined histologically and microscopically. The results showed that administration of MSM before Alendronate inducing ulcer led to a reduction in ulceration and showed significant difference comparing with morbidity group.

Conclusion: MSM (400 mg/kg/day) has protective effect of colon ulcer induced by alendronate.



Yamada T, Alpers DH, Kalloo AN, Kaplowitz N, Owyang C, Powell DW. Textbook of gastroenterology, 5th ed., Chichester, 2009.

Lichtenberger LM, Romero JJ, Gibson GW, Blank MA. Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa. Dig Dis Sci 2000; 45: 1792-1801. https://doi.org/10.1023/A:1005574009856

Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: A pilot clinical trial. Osteoarthr Cartil 2006; 14: 286-294. https://doi.org/10.1016/j.joca.2005.10.003

Horváth KS.A, Noker PE, Somfai-Relle S, Glávits R, Financsek I. Toxicity of methylsulfonylmethane in rats. Food Chem Toxicol 2002; 40: 1459-1462.

?ener G, Kapucu C, Cetinel S, Cikler E, Ayano?lu-Dülger G. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa. Prostaglandins Leukot Essent Fat Acids 2005; 72: 1-11. https://doi.org/10.1016/j.plefa.2004.04.005

Amirshahrokhi K, Bohlooli S, Chinifroush MM. The effect of methylsulfonylmethane on the experimental colitis in the rat. Toxicol Appl Pharmacol 2011; 253: 197-202. https://doi.org/10.1016/j.taap.2011.03.017

Al Bitar V, Laham S. Mtyhylsulfonylmethan and green tea extract reduce oxidative stress and inflammation in an ulcerative colitis. Asian J Pharm Clin Res 2013; 6: 153-158.

Medhi B, Prakasha A, Avti K, Saikia UN, Pandhia P, Khanduja KL. Effect of manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats. Indian J Exp Biol 2008; 46: 583-590. https://doi.org/10.1177/073346488700600302

Sawhney MS, Nelson DB. Alendronate-induced colon ulcers: case report of a new clinical entity. Am Soc Gastrointest Endosc 2004; 60: 14-16.

D’Ovidio V, Aratari A, Viscido A, Marcheggiano A, Papi C, Capurso L, Caprilli R. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. Dig Liver Dis 2006; 38: 389-394. https://doi.org/10.1016/j.dld.2005.12.005

Nagar AB. Isolated colonic ulcers: Diagnosis and management. Curr Gastroenterol Rep 2007; 9: 422-428. https://doi.org/10.1007/s11894-007-0053-9

Morris G, Beck P, Herridge M, Depew W, Szewczuk M, Wallace J. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803. https://doi.org/S0016508589001058[pii

Di Paola R, Mazzon E, Patel NSA, Genovese T, Muià C, Thiemermann C, De Sarro A, Cuzzocrea S. Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid. Eur J Pharmacol 2005; 507: 281-289. https://doi.org/doi:10.1016/j.ejphar.2004.11.041

Nagib MM, Tadros MG, Elsayed MI, Khalifa AE. Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats. Toxicol Appl Pharmacol 2013; 271: 106-113. https://doi.org/10.1016/j.taap.2013.04.026

S.-M. F, D.-L. A, Role of cytokines in inflammatory bowel disease. World J Gastroenterol 2008; 14: 4280-4288.

N. SP, Darvin P, Yoo YB, et al. The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts. BMC Cancer 2015; 15: 474. https://doi.org/10.1186/s12885-015-1445-0

Bohlooli S, Mohammadi S, Amirshahrokhi K, et al. Effect of methylsulfonylmethane pretreatment on acetaminophen induced hepatotoxicity in rats. Iran J Basic Med Sci 2013; 16: 896-900.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2017 Safaa William Mdawar , Shaza Anwar Al Laham , Ahmad Izzat Al-Manadili